Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer
Authors:
- Ralph B. D'AGostinoRDRalph B. D'AGostino
- Karin Drotschmann ScarpinatoKSKarin Drotschmann Scarpinato
- 16 October 2006
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 67 (2) , 214-225
Abstract
Background: Defects in mismatch repair (MMR) proteins have been identified in various types of cancer. However, an association with prostate cancer has been controversial. Defective MMR results in genome instability with detrimental consequences that significantly contribute to tumorigenesis. This study determined alterations in key MMR protein levels in prostate cancer with the goal to identify prognostic markers.Methods: Prostatectomy samples were immunohistochemically stained and the relative presence or absence of key proteins MSH2, MLH1, and PMS2 determined. Cancer tissue of distinct grades was compared with the normal surrounding tissue. Microsatellite instability (MSI) in altered tissues was determined according to NCI guidelines.Results: In contrast to reports that associate a lack of individual MMR proteins with tumorigenesis, a significant increase in PMS2 levels was identified in PIN lesions and prostate cancer tissue. This elevation in PMS2 was independent of changes in levels in its heterodimeric partner, MLH1. Prostate tumors with elevated levels of PMS2 were genetically unstable, which was corrected by MLH1 co‐elevation.Conclusions: This is the first documentation of detrimental consequences associated with the increase in a MMR protein in human cancer. This study recognizes PMS2 elevation as a prognostic marker in pre‐neoplastic and prostate cancer lesions. This result has significant implications for future diagnostic and treatment measures. ProstateKeywords
This publication has 29 references indexed in Scilit:
- Overexpression of the DNA mismatch repair factor, PMS2, confers hypermutability and DNA damage toleranceCancer Letters, 2006
- Molecular pathology of prostate cancerPathology International, 2005
- Clinicopathologic Implications ofhMSH2Gene ExpressionCancer Biology & Therapy, 2002
- Molecular disorders in transitionalvs. peripheral zone prostate adenocarcinomaInternational Journal of Cancer, 2001
- DNA Mismatch Repair Enzyme Activity and Gene Expression in Prostate CancerBiochemical and Biophysical Research Communications, 2001
- Inactivation of DNA Mismatch Repair by Increased Expression of Yeast MLH1Molecular and Cellular Biology, 2001
- Low frequency of allelic imbalance at the prostate cancer susceptibility lociHPC1 and 1p36 in Swedish men with hereditary prostate cancerGenes, Chromosomes and Cancer, 2000
- Microsatellite instability in latent prostate cancersInternational Journal of Cancer, 1996
- Microsatellite Instability and Other Molecular Abnormalities in Human Prostate CancerJapanese Journal of Cancer Research, 1995
- Stromal-epithelial interactions—I. Induction of prostatic phenotype in urothelium of testicular feminized (Tfm/y) miceThe Journal of Steroid Biochemistry and Molecular Biology, 1981